Durvalumab after definitive chemoradiotherapy in locally advanced NSCLC: Data of the German EAP

por Faehling, Martin, Schumann, Christian, Christopoulos, Petros, Hoffknecht, Petra, Alt, Jürgen, Horn, Marlitt, Eisenmann, Stephan, Schlenska-Lange, Anke, Schütt, Philipp, Steger, Felix, Brückl, Wolfgang M., Christoph, Daniel C.
Publicado 2020

Activation of Angiogenesis Differs Strongly Between Pulmonary Carcinoids and Neuroendocrine Carinomas and Is Crucial for Carcinoid Tumourgenesis

por Mairinger, Fabian D., Walter, Robert F. H., Werner, Robert, Christoph, Daniel C., Ting, Saskia, Vollbrecht, Claudia, Zarogoulidis, Konstantinos, Huang, Haidong, Li, Qiang, Schmid, Kurt W., Wohlschlaeger, Jeremias, Zarogoulidis, Paul
Publicado 2014

Cancer-Associated Fibroblasts Influence Survival in Pleural Mesothelioma: Digital Gene Expression Analysis and Supervised Machine Learning Model

por Borchert, Sabrina, Mathilakathu, Alexander, Nath, Alina, Wessolly, Michael, Mairinger, Elena, Kreidt, Daniel, Steinborn, Julia, Walter, Robert F. H., Christoph, Daniel C., Kollmeier, Jens, Wohlschlaeger, Jeremias, Mairinger, Thomas, Brcic, Luka, Mairinger, Fabian D.
Publicado 2023

A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer

por Zhang, Zhenyang, Xie, Shuhan, Cai, Weijing, Hong, Zhi-Nuan, Yang, Chuangcai, Lin, Yukang, Zhu, Jiafu, Lin, Zhiwei, Christoph, Daniel C., Bohnenberger, Hanibal, Kepka, Lucyna, Brueckl, Wolfgang M., Van Houtte, Paul, Kang, Mingqiang, Lin, Jiangbo
Publicado 2022

Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheli...

por Mathilakathu, Alexander, Borchert, Sabrina, Wessolly, Michael, Mairinger, Elena, Beckert, Hendrik, Steinborn, Julia, Hager, Thomas, Christoph, Daniel C., Kollmeier, Jens, Wohlschlaeger, Jeremias, Mairinger, Thomas, Schmid, Kurt Werner, Walter, Robert F. H., Brcic, Luka, Mairinger, Fabian D.
Publicado 2021

Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program

por Frost, Nikolaj, Christopoulos, Petros, Kauffmann-Guerrero, Diego, Stratmann, Jan, Riedel, Richard, Schaefer, Monica, Alt, Jürgen, Gütz, Sylvia, Christoph, Daniel C., Laack, Eckart, Faehling, Martin, Fischer, Richard, Fenchel, Klaus, Haen, Sebastian, Heukamp, Lukas, Schulz, Christian, Griesinger, Frank
Publicado 2021

Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in Immunogenicity

por Brcic, Luka, Mathilakathu, Alexander, Walter, Robert F. H., Wessolly, Michael, Mairinger, Elena, Beckert, Hendrik, Kreidt, Daniel, Steinborn, Julia, Hager, Thomas, Christoph, Daniel C., Kollmeier, Jens, Mairinger, Thomas, Wohlschlaeger, Jeremias, Schmid, Kurt Werner, Borchert, Sabrina, Mairinger, Fabian D.
Publicado 2021

Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy

por Mairinger, Fabian D., Schmeller, Jan, Borchert, Sabrina, Wessolly, Michael, Mairinger, Elena, Kollmeier, Jens, Hager, Thomas, Mairinger, Thomas, Christoph, Daniel C., Walter, Robert F.H., Eberhardt, Wilfried E.E., Plönes, Till, Wohlschlaeger, Jeremias, Jasani, Bharat, Schmid, Kurt Werner, Bankfalvi, Agnes
Publicado 2018

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

por Borchert, Sabrina, Wessolly, Michael, Schmeller, Jan, Mairinger, Elena, Kollmeier, Jens, Hager, Thomas, Mairinger, Thomas, Herold, Thomas, Christoph, Daniel C., Walter, Robert F. H., Eberhardt, Wilfried E. E., Plönes, Till, Wohlschlaeger, Jeremias, Aigner, Clemens, Schmid, Kurt Werner, Mairinger, Fabian D.
Publicado 2019

Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53

por Walter, Robert F. H., Werner, Robert, Wessolly, Michael, Mairinger, Elena, Borchert, Sabrina, Schmeller, Jan, Kollmeier, Jens, Mairinger, Thomas, Hager, Thomas, Bankfalvi, Agnes, Christoph, Daniel C., Eberhardt, Wilfried E. E., Plönes, Till, Aigner, Clemens, Schmid, Kurt W., Wohlschlaeger, Jeremias, Mairinger, Fabian D.
Publicado 2018

Processing Escape Mechanisms Through Altered Proteasomal Cleavage of Epitopes Affect Immune Response in Pulmonary Neuroendocrine Tumors

por Wessolly, Michael, Walter, Robert F. H., Vollbrecht, Claudia, Werner, Robert, Borchert, Sabrina, Schmeller, Jan, Mairinger, Elena, Herold, Thomas, Streubel, Anna, Christoph, Daniel C., Eberhardt, Wilfried E. E., Kollmeier, Jens, Mairinger, Thomas, Schmid, Kurt W., Wohlschlaeger, Jeremias, Hager, Thomas, Mairinger, Fabian D.
Publicado 2018

Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study)

por Zeuschner, Philip, Hölters, Sebastian, Stöckle, Michael, Seliger, Barbara, Mueller, Anja, Bachmann, Hagen S., Grünwald, Viktor, Christoph, Daniel C., Stenzl, Arnulf, Grimm, Marc-Oliver, Brüning, Fabian, Goebell, Peter J., Augustin, Marinela, Roos, Frederik, Harde, Johanna, Benz-Rüd, Iris, Staehler, Michael, Junker, Kerstin
Publicado 2021

First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up

por Jia, Ziqi, Wang, Yanyu, Cao, Lei, Wang, Yadong, Song, Yang, Yang, Xiaoying, Bing, Zhongxing, Cao, Zhili, Liu, Peng, Zhang, Shuyang, Chen, Zexin, Huang, Min, Yu, Yan, Han-Zhang, Han, Song, Jinlei, Christoph, Daniel C., Passaro, Antonio, Gridelli, Cesare, Hishida, Tomoyuki, Liang, Naixin, Li, Shanqing
Publicado 2020